Jext (Epinephrine Bitartrate)

Epinephrine is a non‑selective agonist of alpha‑ and beta‑adrenergic receptors. Stimulation of alpha‑1 receptors causes vasoconstriction, raising blood pressure; beta‑1 activation increases heart rate and contractility; beta‑2 activation relaxes bronchial smooth muscle, producing bronchodilation and reducing mediator release from mast cells. This combined effect quickly counteracts anaphylactic shock.

The specific dose of Jext is determined by the prescribing clinician based on the patient’s age, weight, and severity of the reaction. In emergency settings, a standard adult dose is often 0.3 mg administered intramuscularly, but exact dosing must follow local guidelines and the prescriber’s order.

Epinephrine is classified as Pregnancy Category C; it should be used only when the potential benefit justifies the potential risk to the fetus. Limited data are available for breastfeeding, but small amounts may be excreted in milk. Clinicians should weigh risks and benefits and monitor mother and infant closely.

To request Jext, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and necessary import documentation.

Jext delivers epinephrine bitartrate in an intramuscular injection, similar to other auto‑injectors and ampoules. Compared with auto‑injectors, Jext may offer flexibility in dose selection and is suited for professional administration. Its pharmacologic profile is equivalent to other epinephrine formulations, providing rapid alpha‑ and beta‑adrenergic stimulation.

Jext should be stored at ambient temperature, below 25 °C, in its original packaging to protect from moisture and light. Do not freeze the product. Before use, inspect the vial for particulate matter or discoloration and allow it to reach room temperature if it has been refrigerated during transport.

Jext is supplied as a sterile solution for intramuscular injection, typically into the lateral thigh (vastus lateralis). The healthcare professional draws the prescribed volume into a syringe, removes air bubbles, and injects swiftly. Proper aseptic technique and correct anatomical site are essential for effective drug delivery.

The most serious adverse reactions include severe hypertension, cardiac arrhythmias, myocardial ischemia, and, rarely, cerebrovascular hemorrhage. These events are more likely in patients with underlying cardiovascular disease or when excessive doses are administered. Immediate medical monitoring is required after injection.

Jext is contraindicated in individuals with known hypersensitivity to epinephrine or any component of the formulation. Caution is advised, and use may be avoided, in patients with uncorrected thyrotoxicosis, severe peripheral vascular disease, or those on non‑selective β‑blockers where the therapeutic response may be impaired.